Exelixis Announces October 27th Webcast of Third Quarter 2011 Financial Results Conference Call

Show Health and Fitness Publications

Thu, October 27, 2011

[ Thu, Oct 27th 2011 ] - Market Wire

Unity Powers Army OneSource Virtual World

[ Thu, Oct 27th 2011 ] - Market Wire

Biogen Idec en Portola Pharmaceuticals kondigen i .. n voor oraal syk-remmerprogramma gericht op auto-

[ Thu, Oct 27th 2011 ] - Market Wire

Pfizer Declares A 20-Cent Fourth-Quarter 2011 Dividend

[ Thu, Oct 27th 2011 ] - Market Wire

Crystal Research Associates, LLC Issues Executive .. al Overview (EIO) on Adamis Pharmaceuticals Corp.

[ Thu, Oct 27th 2011 ] - Market Wire

FMX Ventures Inc. and Tolima Gold Corp. Announce .. or and Commencement of Private Placement Offering

[ Thu, Oct 27th 2011 ] - Market Wire

Cannabis Science Releases First Cannabis-Extract- .. Now at Cannabis Therapeutics, 957 E. Fillmore St,

[ Thu, Oct 27th 2011 ] - Market Wire

Biogen Idec e Portola Pharmaceuticals hanno annun .. ale per Oral Syk, il programma inibitore specific

[ Thu, Oct 27th 2011 ] - Market Wire

Biogen Idec et Portola Pharmaceuticals annoncent .. ns le cadre daun programme dainhibiteur oral de l

[ Thu, Oct 27th 2011 ] - Market Wire

Biogen Idec und Portola Pharmaceuticals verknden .. rogramm fr den oral verabreichten SYK-Inhibitor b

[ Thu, Oct 27th 2011 ] - Market Wire

Health Net Federal Services Launches Mobile Site .. he-Go Access to Health Care for Military Families

[ Thu, Oct 27th 2011 ] - Market Wire

Human Genome Sciences and Xoma Fall Victim to Volatile Nature of Biotech Sector

[ Thu, Oct 27th 2011 ] - Market Wire

PharmaGap Sets Time for in Vivo Tests

[ Thu, Oct 27th 2011 ] - Market Wire

Dynavax Phase 3 Data in Chronic Kidney Disease De .. rates Superiority of HEPLISAV(TM) vs Engerix-B(R)

[ Thu, Oct 27th 2011 ] - Market Wire

Implant Sciences Explosives Detection Technology Protects Major European Bank

[ Thu, Oct 27th 2011 ] - Market Wire

Incyte Reports Third Quarter 2011 Financial Results and Provides Update on Key Clinical Programs

[ Thu, Oct 27th 2011 ] - Market Wire

Acorda Therapeutics to Host Conference Call to Di .. uarter 2011 Financial Results on November 4, 2011

[ Thu, Oct 27th 2011 ] - Market Wire

ICON Reports Q3 revenue growth of 7% to $241 mill .. f $431 million. (NASDAQ:ICLR) (ISIN:IE0005711209)

[ Thu, Oct 27th 2011 ] - Market Wire

Pfizer Receives European Approval to Extend Use o .. ars and Older for the Prevention of Invasive Pneu

Wed, October 26, 2011

[ Wed, Oct 26th 2011 ] - Market Wire

Universal American Corp. Reports Third Quarter 2011 Results

[ Wed, Oct 26th 2011 ] - Market Wire

Baxter to Present at the Credit Suisse 2011 Healthcare Conference

[ Wed, Oct 26th 2011 ] - Market Wire

Medtronic Starts Landmark Study of Hypertension Treatment

[ Wed, Oct 26th 2011 ] - Market Wire

Biogen Idec oglasza pozytywne podsumowanie wynikw .. 3. badan nad doustnym BG-12 u pacjentw ze stward

[ Wed, Oct 26th 2011 ] - Market Wire

Stellar Biotechnologies &;; Life Diagno .. e Agreement for Stellar Brand KLH ELISA Test Kits

[ Wed, Oct 26th 2011 ] - Market Wire

2011 Third Quarter and Nine-Month Results

[ Wed, Oct 26th 2011 ] - Market Wire

Seattle Genetics Appoints Vice President, Medical .. nces Vice President, Quality Management Promotion

[ Wed, Oct 26th 2011 ] - Market Wire

Abiomed to Release New Protect II Data and Econom .. #59; Over 20 Impella Presentations Included i

[ Wed, Oct 26th 2011 ] - Market Wire

Health Canada Clears Immunovaccine for Ovarian Cancer Vaccine Trials

[ Wed, Oct 26th 2011 ] - Market Wire

Cytori to Webcast Third Quarter Financial Results November 3

[ Wed, Oct 26th 2011 ] - Market Wire

Magellan Health Services Joins with Share Our Strength to End Childhood Hunger in America

[ Wed, Oct 26th 2011 ] - Market Wire

Octapharma Locks-in Binding Forecast to Exceed $2M for ProMetic's Prion Capture Resin for H1 2012

[ Wed, Oct 26th 2011 ] - Market Wire

Amedisys Announces Third Quarter Earnings Release and Conference Call Date

[ Wed, Oct 26th 2011 ] - Market Wire

Covidien Launches Worldas First Non-Absorbable, Uni-Directional Knotless Suture

[ Wed, Oct 26th 2011 ] - Market Wire

Biogen Idec annonce des rsultats trs positifs l'i .. se 3 tudiant BG-12 (dimthylfumarate) administr pa

[ Wed, Oct 26th 2011 ] - Market Wire

Biogen Idec annuncia risultati preliminari positi .. ico di fase III del farmaco orale BG-12 (dimetilf

[ Wed, Oct 26th 2011 ] - Market Wire

Biogen Idec Announces Positive Top-Line Results f .. stigating Oral BG-12 (Dimethyl Fumarate) in Multi

[ Wed, Oct 26th 2011 ] - Market Wire

Biogen Idec meldet positive Topline-Ergebnisse au .. zur Prfung von oral verabreichtem BG-12 (Dimethyl

Tue, October 25, 2011

[ Tue, Oct 25th 2011 ] - Market Wire

West to Host 2011 Third Quarter Conference Call

[ Tue, Oct 25th 2011 ] - Market Wire

CytoSorbents Corporation to Present at the IN3 Medical Device Summit

[ Tue, Oct 25th 2011 ] - Market Wire

Bard Announces Agreement to Acquire Medivance, Inc.

[ Tue, Oct 25th 2011 ] - Market Wire

USANA Health Sciences Reports Third Quarter 2011 Financial Results

[ Tue, Oct 25th 2011 ] - Market Wire

Micro Imaging Technology Receives a Substantial Exclusive Licensing Proposal From EPIC Corporation

[ Tue, Oct 25th 2011 ] - Market Wire

Daniel Levangie Appointed to Insulet's Board of Directors

[ Tue, Oct 25th 2011 ] - Market Wire

The Law Firm of Levi &;; Korsinsky Noti .. Their Investment in K-V Pharmaceutical Company o

[ Tue, Oct 25th 2011 ] - Market Wire

VistaGen Therapeutics Reports Identification of C .. ts High-Yield Purification of Human Pluripotent S

[ Tue, Oct 25th 2011 ] - Market Wire

Amarantus BioSciences Appoints Dr. Owen Garrick as Strategic Advisor

[ Tue, Oct 25th 2011 ] - Market Wire

What's Ahead: Today's Economic Outlook - Equity R .. earch on Thoratec Corporation and C.R. Bard, Inc.

[ Tue, Oct 25th 2011 ] - Market Wire

Daxor Announces Filing of Patents for Total Body Albumin Analyzer

[ Tue, Oct 25th 2011 ] - Market Wire

OmniGuide Appoints Scott Flora as President & CEO

[ Tue, Oct 25th 2011 ] - Market Wire

ZYTO Corp Appoints Leading Experts to Scientific Advisory Board

[ Tue, Oct 25th 2011 ] - Market Wire

Implant Sciences Sells Follow-On Order to China's Beijing Subway System

[ Tue, Oct 25th 2011 ] - Market Wire

Gilead e GlobeImmune annunciano un contratto di l .. o sviluppo di vaccini terapeutici per il trattame

[ Tue, Oct 25th 2011 ] - Market Wire

Dr. Reddyas Q2 FY12 Financial Results

[ Tue, Oct 25th 2011 ] - Market Wire

Exelixis Appoints Executive Vice President and Chief Commercial Officer

[ Tue, Oct 25th 2011 ] - Market Wire

DaVita Announces Government Inquiry

Mon, October 24, 2011

[ Mon, Oct 24th 2011 ] - Market Wire

Merck Announces Presentation of Phase III Investi .. ULERA (mometasone furoate and formoterol fumarate

[ Mon, Oct 24th 2011 ] - Market Wire

Blinded Results From Low Dose Cohort of Phase II SHIGATEC Trial Presented at IDSA Annual Meeting

[ Mon, Oct 24th 2011 ] - Market Wire

The Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of Adolor Corporation

[ Mon, Oct 24th 2011 ] - Market Wire

Harwood Feffer LLP Announces Investigation of HealthSpring Inc.

[ Mon, Oct 24th 2011 ] - Market Wire

Edison Expands Cell Therapy Sector Presence with Launch of Research Coverage on Aastrom

[ Mon, Oct 24th 2011 ] - Market Wire

Diligent Boardbooks Announces Fifth Consecutive R .. r, Boardbooks Now Used by 62 TSX Listed Companies

[ Mon, Oct 24th 2011 ] - Market Wire

Syneron Medical to Report Third Quarter 2011 Financial Results on November 10, 2011

[ Mon, Oct 24th 2011 ] - Market Wire

What's Ahead: Today's Economic Outlook - Equity R .. on Medtronic, Inc. and The Cooper Companies, Inc.

[ Mon, Oct 24th 2011 ] - Market Wire

What's Ahead: Today's Economic Outlook - Equity R .. Ware International Inc and St. Jude Medical, Inc.

[ Mon, Oct 24th 2011 ] - Market Wire

Growing Safety Concerns Weigh on Medical Equipment and Supplies Sector

[ Mon, Oct 24th 2011 ] - Market Wire

NPS Pharmaceuticals Reports Upcoming Presentation .. ege of Gastroenterology Annual Scientific Meeting

[ Mon, Oct 24th 2011 ] - Market Wire

Cigna to Acquire HealthSpring

[ Mon, Oct 24th 2011 ] - Market Wire

PharmaGap Chooses Ovarian Cancer as Target for First Clinical Trials

[ Mon, Oct 24th 2011 ] - Market Wire

Research on GlaxoSmithKline plc and Merck &;; Co. Inc. -- Big Pharma Stable for Now

[ Mon, Oct 24th 2011 ] - Market Wire

SecureAlert, Inc. Achieves Milestone of Deploymen .. Units of Its Newest ReliAlert(TM) GPS Tracking a

[ Mon, Oct 24th 2011 ] - Market Wire

Aeolus Pharmaceuticals Announces NIH Counteract G .. 10150 as a Treatment Against Nerve Agent Exposure

[ Mon, Oct 24th 2011 ] - Market Wire

Novadaq to Release Q3-2011 Financial Results on November 4-Conference Call to Follow

[ Mon, Oct 24th 2011 ] - Market Wire

Waters Recognizes the Dr. Ganesh Anand Laboratory .. l University of Singapore as Center of Innovation

Sat, October 22, 2011

[ Sat, Oct 22nd 2011 ] - Market Wire

Biogen Idec und Abbott prsentieren positive Daten .. ase-IIb-Studie SELECT auf dem ECTRIMS/ACTRIMS-Kon

[ Sat, Oct 22nd 2011 ] - Market Wire

Zimmer presenta il sistema a vite pedicolare Path .. minimamente invasivo destinato al mercato europeo

[ Sat, Oct 22nd 2011 ] - Market Wire

Biogen Idec en Abbott presenteren positieve resul .. P uit Select fase 2b onderzoek op ECTRIMS/ACTRIMS

[ Sat, Oct 22nd 2011 ] - Market Wire

Biogen Idec et Abbott pr©sentent les r©sultats .. phase 2b pour le Daclizumab HYP lors du congrs EC

Fri, October 21, 2011

[ Fri, Oct 21st 2011 ] - Market Wire

Kahn Swick &;; Foti, LLC and Former Lou .. nce Securities Class Action Lawsuit Against K-V P

[ Fri, Oct 21st 2011 ] - Market Wire

Data From Phase 2 Clinical Studies of Telotristat .. rcinoid Syndrome to be Presented at North America

[ Fri, Oct 21st 2011 ] - Market Wire

Valeant Pharmaceuticals to Announce 2011 Third Quarter Results on November 3, 2011

[ Fri, Oct 21st 2011 ] - Market Wire

Federman &;; Sherwood Announces That a .. it Has Been Filed Against K-V Pharmaceutical Comp

[ Fri, Oct 21st 2011 ] - Market Wire

AMAG Pharmaceuticals Announces Results of Special Stockholder Meeting Regarding Proposed Merger

[ Fri, Oct 21st 2011 ] - Market Wire

Dynavax and GlaxoSmithKline Expand Their Worldwide Strategic Alliance

[ Fri, Oct 21st 2011 ] - Market Wire

Additional Data From Pfizera?s Prevnar 13® Clini .. And Older To Be Presented At The 49th Annual Meet

[ Fri, Oct 21st 2011 ] - Market Wire

Wall Street Reporter, Inc. Interviews Micro Imagi .. echnology, Inc. Chairman and CEO, Michael Brennan

[ Fri, Oct 21st 2011 ] - Market Wire

AVI BioPharma's RNA-Based Therapeutics for Treatm .. ses Show Positive Safety Data in First Five of Si

[ Fri, Oct 21st 2011 ] - Market Wire

For The Earth Corporation Strengthens Its Portfolio With Kat Box King

[ Fri, Oct 21st 2011 ] - Market Wire

GTx, Inc. To Host Third Quarter 2011 Financial Results Conference Call and Webcast

[ Fri, Oct 21st 2011 ] - Market Wire

Teleflex Signs Definitive Agreement to Sell Aerospace Businesses for $280 Million

[ Fri, Oct 21st 2011 ] - Market Wire

Magellan Health Services to Present at Academy of Managed Care Pharmacy Educational Conference

[ Fri, Oct 21st 2011 ] - Market Wire

Oral BG-12 (Dimetil Fumarato) reduce notablemente .. con esclerosis multiple (MS) y el avance de la d

[ Fri, Oct 21st 2011 ] - Market Wire

Oraal toegediende BG-12 (dimethyl fumaraat) reduc .. lerose en voortschrijding aftakeling in Fase 3 DE

[ Fri, Oct 21st 2011 ] - Market Wire

Acorda Therapeutics Announces Data on AMPYRA® Pr .. h Joint Triennial Congress of ECTRIMS and ACTRIMS

[ Fri, Oct 21st 2011 ] - Market Wire

Reduzierte Schubhufigkeit und Behinderungsprogres .. durch oral verabreichtes BG-12 (Dimethylfumarat):

[ Fri, Oct 21st 2011 ] - Market Wire

Selon les observations de l'essai clinique DEFINE .. -12 (dim©thylfumarate) r©duit de manire signifi

Thu, October 20, 2011

[ Thu, Oct 20th 2011 ] - Market Wire

Biogen Idec und Elan melden Verlngerung der PDUFA-Frist

[ Thu, Oct 20th 2011 ] - Market Wire

Biogen Idec y Elan reciben notificacin de ampliacin de la fecha PDUFA

[ Thu, Oct 20th 2011 ] - Market Wire

Critical Outcome Technologies Inc. Successfully Completes Critical Study

[ Thu, Oct 20th 2011 ] - Market Wire

Analyst View, Impact of Global Events - Research .. on &;; Johnson and Endo Pharmaceuticals

[ Thu, Oct 20th 2011 ] - Market Wire

Dendreon Announces Webcast Presentations at Upcoming Conferences

[ Thu, Oct 20th 2011 ] - Market Wire

Biogen Idec and Elan Receive Notification of PDUFA Date Extension

[ Thu, Oct 20th 2011 ] - Market Wire

Alnylam to Webcast Presentation at the Newsmakers in the Biotech Industry 2011 Conference

[ Thu, Oct 20th 2011 ] - Market Wire

Allon Therapeutics Announces Completion of Patient Enrollment in Pivotal Trial

[ Thu, Oct 20th 2011 ] - Market Wire

POZEN Announces November 3, 2011 Webcast of Third Quarter 2011 Results

[ Thu, Oct 20th 2011 ] - Market Wire

Geron Presents Clinical Data Update From GRNOPC1 Spinal Cord Injury Trial

[ Thu, Oct 20th 2011 ] - Market Wire

Cambridge Heart Announces Initial Results of OEM Module Marketing Promotion

[ Thu, Oct 20th 2011 ] - Market Wire

Manchester Heart Centre in United Kingdom Obtains VMS(TM) Heart Analysis System

[ Thu, Oct 20th 2011 ] - Market Wire

Covidien Releases Clinical Data from Largest Pros .. Plaque Excision for Treatment of Peripheral Arter

[ Thu, Oct 20th 2011 ] - Market Wire

Five Star Quality Care, Inc. Third Quarter Conference Call Scheduled for Thursday, October 27th

[ Thu, Oct 20th 2011 ] - Market Wire

Capital Senior Living Corporation Closes Three Community $30 Million Acquisition

[ Thu, Oct 20th 2011 ] - Market Wire

Syneron kndigt weltweite Einfhrung einer neuen Ko .. echnologien fr die Gesichtsbehandlung mit dem eTw

[ Thu, Oct 20th 2011 ] - Market Wire

Device Master File for OncoSec Medical System Completed and Submitted to FDA

[ Thu, Oct 20th 2011 ] - Market Wire

Comprehensive Care Corporation CEO Clark A. Marcus Praised for U.S. Chamber of Commerce Service

Wed, October 19, 2011

[ Wed, Oct 19th 2011 ] - Market Wire

Sun Healthcare Group, Inc. to Release Third-Quarter Results for 2011 and Schedules Conference Call

[ Wed, Oct 19th 2011 ] - Market Wire

CML HealthCare Inc. Declares October Dividend

[ Wed, Oct 19th 2011 ] - Market Wire

Allied Healthcare International Inc. Shareholders Approve Acquisition by Saga Group Limited

[ Wed, Oct 19th 2011 ] - Market Wire

Health Canada Approval for Verisante Aura(TM) Marks Milestone in Skin Cancer Detection

[ Wed, Oct 19th 2011 ] - Market Wire

Gegevens over vroeg gebruik en baten op lange ter .. d op 5de gezamenlijk driejaarlijks congres over b

[ Wed, Oct 19th 2011 ] - Market Wire

Des r©sultats relatifs l'utilisation pr©coce et .. YSABRI sont pr©sent©s l'occasion du 5e Congrs t

[ Wed, Oct 19th 2011 ] - Market Wire

Los datos sobre el uso temprano y los beneficios .. sido presentados en el 5 congreso trienal conjun

[ Wed, Oct 19th 2011 ] - Market Wire

Theratechnologies Announces Application for Registration of Tesamorelin in Mexico

[ Wed, Oct 19th 2011 ] - Market Wire

Diligent Board Member Services Ranked Number 156 .. rth America on Deloitte's 2011 Technology Fast 50

[ Wed, Oct 19th 2011 ] - Market Wire

Marina Biotech Demonstrates In Vivo Dose-Dependen .. erability With a CRN-Substituted miRNA Antagonist

[ Wed, Oct 19th 2011 ] - Market Wire

Ardea Biosciences to Present Data From Gout Program at the 2011 ACR/ARHP Annual Scientific Meeting

[ Wed, Oct 19th 2011 ] - Market Wire

UNITEDHEALTHCARE OFRECE AUDFONOS SIN COSTO DE DES .. PARA LOS BENEFICIARIOS DEL CONDADO DE MIAMI-DADE

[ Wed, Oct 19th 2011 ] - Market Wire

Vertex Submits Application for Priority Review an .. 770, ivacaftor) in the U.S. as First Potential Me

[ Wed, Oct 19th 2011 ] - Market Wire

Ligand Enters into Platform Captisol® License Agreement with SAGE Therapeutics

[ Wed, Oct 19th 2011 ] - Market Wire

Single Pharmaceutical-Based Strategy Aims to Solve Neurological and Psychiatric Disorders

[ Wed, Oct 19th 2011 ] - Market Wire

Daten ber Vorteile frhzeitiger bzw. langfristiger .. f 5. dreijhrlichem gemeinsamem Kongress von ECTRI

[ Wed, Oct 19th 2011 ] - Market Wire

Astex Pharmaceuticals to Present at BIO Investor Forum on October 26th

[ Wed, Oct 19th 2011 ] - Market Wire

Presentati al 5o congresso triennale congiunto di .. ivi alla?uso precoce e ai vantaggi a lungo termin

Tue, October 18, 2011

[ Tue, Oct 18th 2011 ] - Market Wire

Law Office of Brodsky & Smith, LLC Announces Investigation of Anadys Pharmaceticals, Inc.

[ Tue, Oct 18th 2011 ] - Market Wire

Vanda Pharmaceuticals to Announce Third Quarter 2011 Financial Results on November 4, 2011

[ Tue, Oct 18th 2011 ] - Market Wire

Cytokinetics Announces Strategic Restructuring

[ Tue, Oct 18th 2011 ] - Market Wire

Greatbatch, Inc. to Host Third Quarter 2011 Earnings Conference Call on October 27, 2011

[ Tue, Oct 18th 2011 ] - Market Wire

Aetna Earns J.D. Power and Associates 2011 Call Center Certification

[ Tue, Oct 18th 2011 ] - Market Wire

Brower Piven Encourages Investors Who Have Losses .. vestment in Stereotaxis, Inc. to Inquire About th

[ Tue, Oct 18th 2011 ] - Market Wire

Exactech Schedules Third Quarter 2011 Earnings Release and Conference Call

[ Tue, Oct 18th 2011 ] - Market Wire

Allon Therapeutics Completes Equity Offering

[ Tue, Oct 18th 2011 ] - Market Wire

Flamel Technologies Announces Multi-Year Supply A .. ith GlaxoSmithKline for Coreg CRa" Microparticles

[ Tue, Oct 18th 2011 ] - Market Wire

MethylGene Receives FDA IND Approval to Begin a P .. ith MGCD290, a Novel Antifungal Product Candidate

[ Tue, Oct 18th 2011 ] - Market Wire

Human Genome Sciences to Sponsor Conference Call to Discuss Third Quarter 2011 Financial Results

[ Tue, Oct 18th 2011 ] - Market Wire

ISTA Pharmaceuticals Announces Conference Call and Webcast of Third Quarter 2011 Financial Results

[ Tue, Oct 18th 2011 ] - Market Wire

Given Imaging Announces New Study Shows Impact of .. lCam(R) SB on Management of Symptomatic IBD Cases

[ Tue, Oct 18th 2011 ] - Market Wire

Dr. Roberto Romero, NIH Principal Investigator of .. by Columbia Laboratories, Honored with John Ding

[ Tue, Oct 18th 2011 ] - Market Wire

Reflect Scientific, Inc. Introduces Cryometrix Model B-120 Blast Freezer

[ Tue, Oct 18th 2011 ] - Market Wire

Greystone Logistics Announces Preliminary Financial Results for 1st Quarter

[ Tue, Oct 18th 2011 ] - Market Wire

DaVita Announces Estimate of Third Quarter 2011 Results

Mon, October 17, 2011

[ Mon, Oct 17th 2011 ] - Market Wire

Afexa Announces Take-Up of Shares Under Valeant Offer

[ Mon, Oct 17th 2011 ] - Market Wire

Izard Nobel LLP Announces Class Action Lawsuit Against Stereotaxis, Inc.

[ Mon, Oct 17th 2011 ] - Market Wire

Medtronic Elects Michael O. Leavitt to the Board of Directors

[ Mon, Oct 17th 2011 ] - Market Wire

Cubist Pharmaceuticals Appoints Jennifer Jackson as Senior Vice President, Regulatory Affairs

[ Mon, Oct 17th 2011 ] - Market Wire

Tripp Levy PLLC Announces Investigation of Anadys Pharmaceuticals

[ Mon, Oct 17th 2011 ] - Market Wire

Futuremed Announces Timing of Third Quarter 2011 Results &;; Conference Call

[ Mon, Oct 17th 2011 ] - Market Wire

Leisureworld Announces October Dividend

[ Mon, Oct 17th 2011 ] - Market Wire

Medtronic Announces 510(k) Clearance for the Aqua .. ined Hemostatic Sealing and Cutting Functionality

[ Mon, Oct 17th 2011 ] - Market Wire

PharmStar Outstanding Common Stock Reduced by 50%

[ Mon, Oct 17th 2011 ] - Market Wire

AdCare Health Systems to Acquire Five Skilled Nursing Facilities in Oklahoma

[ Mon, Oct 17th 2011 ] - Market Wire

Lpath Initiates Dosing of iSONEP in Second of Two Proof-of-Concept Trials

[ Mon, Oct 17th 2011 ] - Market Wire

Marina Biotech, Inc. Announces a $15 Million Purc .. ase Agreement With Lincoln Park Capital Fund, LLC

[ Mon, Oct 17th 2011 ] - Market Wire

DMRJ Amends Implant Sciences' Credit Facility

[ Mon, Oct 17th 2011 ] - Market Wire

Immunovaccine Appoints Wayne Pisano to its Board

[ Mon, Oct 17th 2011 ] - Market Wire

Cellceutix Confident as Cancer Compound Shows Activity in All Cancers Tested

[ Mon, Oct 17th 2011 ] - Market Wire

CytoSorbents Corporation Launches HemoDefend Puri .. for Blood Transfusion Applications at the AABB Co

[ Mon, Oct 17th 2011 ] - Market Wire

Acura Pharmaceuticals Provides Update on Opioid Product Licensed to Pfizer

Sun, October 16, 2011

[ Sun, Oct 16th 2011 ] - Market Wire

China Medical Technologies Announces the Approval .. Technology Enterprise Status for a Major Subsidia

Sat, October 15, 2011

[ Sat, Oct 15th 2011 ] - Market Wire

The Medicines Company's MDCO-2010 Meets Clinical .. ectives in Patients Undergoing Open-Heart Surgery

Fri, October 14, 2011

[ Fri, Oct 14th 2011 ] - Market Wire

Newly Published Study Highlights Systemic Growth .. g" Market;; DRM Ventures (DRM) and Patient

[ Fri, Oct 14th 2011 ] - Market Wire

Par Pharmaceutical Files Declaratory Judgment to .. s to Disseminate Truthful Information Regarding M

[ Fri, Oct 14th 2011 ] - Market Wire

Sangamo BioSciences Announces Presentation at the .. ual Newsmakers in the Biotech Industry Conference

[ Fri, Oct 14th 2011 ] - Market Wire

MannKind to Present at The 18th Annual Newsmakers in the BioTech Industry Conference

[ Fri, Oct 14th 2011 ] - Market Wire

Amarillo Biosciences Issues Corporate Update

[ Fri, Oct 14th 2011 ] - Market Wire

Enzo Reports Record Revenues of $102 Million for Fiscal Year 2011

[ Fri, Oct 14th 2011 ] - Market Wire

Greatbatch, Inc. Elects Anthony P. Bihl III to its Board of Directors

[ Fri, Oct 14th 2011 ] - Market Wire

New Data on Tevaa?s Copaxone® and Laquinimod to Be Highlighted at ECTRIMS/ACTRIMS

[ Fri, Oct 14th 2011 ] - Market Wire

Dynavax to Present at Newsmakers in the Biotech Industry Conference

[ Fri, Oct 14th 2011 ] - Market Wire

MSA Completes Sale of North Carolina Ballistic Vest Business

[ Fri, Oct 14th 2011 ] - Market Wire

Faruqi & Faruqi, LLP Announces Investigation of Stereotaxis, Inc.

[ Fri, Oct 14th 2011 ] - Market Wire

Teva Completes Acquisition of Cephalon

[ Fri, Oct 14th 2011 ] - Market Wire

Brookwater Announces Hiring of One of the Largest .. physical &;; Geological Teams in Brazil

[ Fri, Oct 14th 2011 ] - Market Wire

Funding Security Critical to Long Term Success of Biotech Firms

[ Fri, Oct 14th 2011 ] - Market Wire

Skanska Awarded R&D Lab Renovation Contract for USD 80 M, About SEK 512 M

[ Fri, Oct 14th 2011 ] - Market Wire

Columbia Laboratories to Present October 21st at NewsMakers in the Biotech Industry Conference

[ Fri, Oct 14th 2011 ] - Market Wire

Astex Pharmaceuticals to Present at NewsMakers in the Biotech Industry on October 21st

Thu, October 13, 2011

[ Thu, Oct 13th 2011 ] - Market Wire

Kindred Healthcare Commences Registered Exchange Offer for Its 8.25% Senior Notes Due 2019

[ Thu, Oct 13th 2011 ] - Market Wire

Trimel Appoints John Friedrichsen to Its Board of Director

[ Thu, Oct 13th 2011 ] - Market Wire

National Imaging Associates Launches Imaging Demo .. ject for Centers for Medicare & Medicaid Services

[ Thu, Oct 13th 2011 ] - Market Wire

Amarantus BioSciences Announces Close of $10M Equ .. nding Facility With Centurion Private Equity, LLC

[ Thu, Oct 13th 2011 ] - Market Wire

Amica Mature Lifestyles to Announce First Quarter .. esults and Host Conference Call November 14, 2011

[ Thu, Oct 13th 2011 ] - Market Wire

Strong Pipelines From Allos Therapeutics and Dynavax Tech Poised to Pay Off

[ Thu, Oct 13th 2011 ] - Market Wire

High Growth Biotech Firms Zalicus and Sequenom Ready for Knockout Fourth Quarter

[ Thu, Oct 13th 2011 ] - Market Wire

Vanguard Health Systems Appoints Former Tennessee Governor to Board of Directors

[ Thu, Oct 13th 2011 ] - Market Wire

AMRI Appoints New President, India Operations and .. of Project Management a" Pharmaceutical Services

[ Thu, Oct 13th 2011 ] - Market Wire

Synageva BioPharma and Trimeris Announce Special Meetings of Stockholders to Approve Merger

[ Thu, Oct 13th 2011 ] - Market Wire

Mercka?s ISENTRESS® (raltegravir) in Combination .. cal and Immunological Efficacy Versus the Efavire

[ Thu, Oct 13th 2011 ] - Market Wire

POZEN Reports Top-Line Data from Long-Term Safety Study of PA32540

[ Thu, Oct 13th 2011 ] - Market Wire

Micromet Obtains FDA Feedback on Registration Strategy for Blinatumomab in Relapsed/Refractory ALL

[ Thu, Oct 13th 2011 ] - Market Wire

Horizon Pharma Receives U.S. Patent Allowance for DUEXIS(R) in the United States

[ Thu, Oct 13th 2011 ] - Market Wire

U.S. Sales of EGRIFTA(R) Driving Revenue Growth

[ Thu, Oct 13th 2011 ] - Market Wire

Galectin Therapeutics to Announce New Data on the Treatment of Fatty Liver Disease and Fibrosis

[ Thu, Oct 13th 2011 ] - Market Wire

Los datos presentados durante el 5 Congreso trien .. or ECTRIMS y ACTRIMS demuestran el compromiso y l

Exelixis Announces October 27th Webcast of Third Quarter 2011 Financial Results Conference Call

_{//health-fitness.news-articles.net/content/2011/ .. rter-2011-financial-results-conference-call.html}
^{Published in Health and Fitness on Thursday, October 20th 2011 at 13:51 GMT by Market Wire}

SOUTH SAN FRANCISCO, Calif.--([ BUSINESS WIRE ])--Exelixis, Inc. (NASDAQ:EXEL) will release its third quarter 2011 financial results on Thursday, October 27, 2011, after the markets close. The announcement will be followed by a live webcast at 5:00 p.m. EDT/ 2:00 p.m. PDT. During the webcast, Exelixis management will discuss the Companya�s financial results, financial outlook and development program and plans for cabozantinib, and also provide a general business update The webcast may be accessed in the Event Calendar page under Investors at [ http://www.exelixis.com ].

An archived replay of the webcast will be available on the Event Calendar page under Investors at [ http://www.exelixis.com ] and via phone until 11:59 p.m. EST on November 27, 2011. Access numbers for the phone replay are: 888-286-8010 (domestic) and 617-801-6888 (international); the passcode is 64691635.

About Exelixis

Exelixis, Inc. is a biotechnology company committed to developing small molecule therapeutics for the treatment of cancer. Exelixis is focusing its proprietary resources and development efforts exclusively on cabozantinib, its most advanced solely-owned product candidate, in order to maximize the therapeutic and commercial potential of this compound. Exelixis believes cabozantinib has the potential to be a high-quality, differentiated pharmaceutical product that can make a meaningful difference in the lives of patients. Exelixis has also established a portfolio of other novel compounds that it believes have the potential to address serious unmet medical needs. For more information, please visit the company's web site at [ http://www.exelixis.com ].

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire